Health Condition 1: C501- Malignant neoplasm of central portion of breast Health Condition 2: C503- Malignant neoplasm of lower-innerquadrant of breast Health Condition 3: C505- Malignant neoplasm of lower-outerquadrant of breast Health Condition 4: C508- Malignant neoplasm of overlappingsites of breast Health Condition 5: C502- Malignant neoplasm of upper-innerquadrant of breast Health Condition 6: C504- Malignant neoplasm of upper-outerquadrant of breast
Conditions
Interventions
Intervention1: Surgical Intervention: The patients were evaluated for breast cancer. Then, they were further selected as per the inclusion & exclusion criterias. During Intra op, the patients were the
Sponsors
Dr Rajendra meena
Eligibility
Inclusion criteria
Inclusion criteria: All women above the age of 18 years with histologically proven operable breast cancer. SLNB positive for any number of nodes. For whole SLNB planned. Patients with palpable nodes in whom a USG-guided core biopsy has revealed a metastatic breast cancer
Exclusion criteria
Exclusion criteria: Women with inoperable breast cancer Pregnant women Lactating women Women refusing to sign consent form Fixed axillary lymph nodes even after neoadjuvant chemotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.We assume that cost effectiveness of total care offered to women of treated with level-1 will be lower as compared to cost effectiveness of women treated with complete ALND. 2.We hope that long term risk of lymphedema and arm morbidity will be less in women treated with level - 1 compared to complete axillary dissection. We also hope that local-regional (axillary) recurrence will be non-inferior to the patient undergoing complete ALND.Timepoint: 2 year | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Axillary recurrence 2. LymphedemaTimepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactPIYUSH RANJAN MISHRA
All India Institute of Medical Sciences, New Delhi
Outcome results
None listed